The variant, first detected in the U.S. in late March, has now been identified in arriving international travelers through ...

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The ...

The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...